Companies

Hvivo to make return to shareholders from strong 2022 results

Pharmaceutical services company expects full-year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year

Cathal Friel, chairman and co-founder of Poolbeg Pharma: the serial entrepreneur said he would like to do one initial public offering every year.Picture: Fergal Phillips